衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

+852 5292 0089

衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

+852 5292 0089

查詢或預約Enquiry or Appointment

衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

衞生署日間醫療中心牌照
PHF No. DP000363

Day Procedure Centre Licence
PHF No. DP000363

中文 (香港)

“am730” Report: Health Decoding – Second-Generation EGFR Targeted Drugs Bring Hope for Advanced Lung Cancer Patients with Rare Mutations

15/04/2026 by wgadmin Media Coverage

“am730” Report: Health Decoding – Second-Generation EGFR Targeted Drugs Bring Hope for Advanced Lung Cancer Patients with Rare Mutations

LINK:【健康解碼】第二代EGFR標靶藥針對罕見突變晚期肺癌患者現曙光 | am730

Related Posts

“am730” Report: Health Decoding – Targeting Rare EGFR Mutations Improves Treatment Efficacy for Advanced Lung Cancer

15/04/2026 Media Coverage

“am730” Report: Health Decoding – Targeting Rare EGFR Mutations Improves Treatment Efficacy for Advanced Lung Cancer

“Healthcare Thinkers” Report: What If It’s Advanced Colorectal Cancer? Oral Targeted Therapy Extends Life and Restores Quality of Life

15/04/2026 Media Coverage

“Healthcare Thinkers” Report: What If It’s Advanced Colorectal Cancer? Oral Targeted Therapy Extends Life and Restores Quality of Life

“HK01” Report: Targeted Radionuclide Therapy Helps Neuroendocrine Tumor Patients Reduce the Risk of Progression or Death

15/04/2026 Media Coverage

“HK01” Report: Targeted Radionuclide Therapy Helps Neuroendocrine Tumor Patients Reduce the Risk of Progression or Death